Literature DB >> 17643281

Tissue microarrays enabling high-throughput molecular pathology.

Mikiko Takikita1, Joon-Yong Chung, Stephen M Hewitt.   

Abstract

The tissue microarray has enabled high-throughput pathology. Rather than the laborious review of individual slides and issues of assay reproducibility across large series of specimens, tissue microarrays allow the review of a single stain on a single slide containing tens to hundreds of samples. This is a paradigm shift in pathology, away from histomorphology and toward molecular characterization by immunohistochemistry. This platform allows large retrospective clinical studies of biomarkers for correlation with outcome and can equally well be applied toward high-throughput analysis of cell lines and xenografts. Tissue microarrays encourage novel approaches to assaying tissue with retained histomorphology and have enabled image analysis in pathology. The reduction of tissue to an analyte for high-throughput analysis has highlighted the importance of a high quality tissue and the impact of tissue handling and processing in the quality of data that can be obtained from analysis of tissue.

Mesh:

Year:  2007        PMID: 17643281     DOI: 10.1016/j.copbio.2007.05.007

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  16 in total

Review 1.  Genomic profiling of mesenchymal stem cells.

Authors:  Danijela Menicanin; P Mark Bartold; Andrew C W Zannettino; Stan Gronthos
Journal:  Stem Cell Rev Rep       Date:  2009-02-18       Impact factor: 5.739

2.  Toponostics of invasive ductal breast carcinoma: combination of spatial protein expression imaging and quantitative proteome signature analysis.

Authors:  Claudia Röwer; Björn Ziems; Anngret Radtke; Oliver Schmitt; Toralf Reimer; Cornelia Koy; Hans-Jürgen Thiesen; Bernd Gerber; Michael O Glocker
Journal:  Int J Clin Exp Pathol       Date:  2011-02-28

3.  Cell and tissue microarray technologies for protein and nucleic acid expression profiling.

Authors:  Marina Cardano; Giuseppe R Diaferia; Maurizio Falavigna; Chiara C Spinelli; Fausto Sessa; Pasquale DeBlasio; Ida Biunno
Journal:  J Histochem Cytochem       Date:  2012-11-19       Impact factor: 2.479

4.  Biomarkers in the age of omics: time for a systems biology approach.

Authors:  Mones S Abu-Asab; Mohamed Chaouchi; Salvatore Alesci; Susana Galli; Majid Laassri; Amrita K Cheema; Fouad Atouf; John VanMeter; Hakima Amri
Journal:  OMICS       Date:  2011-02-14

Review 5.  Histo-proteomic profiling of formalin-fixed, paraffin-embedded tissue.

Authors:  Kant M Matsuda; Joon-Yong Chung; Stephen M Hewitt
Journal:  Expert Rev Proteomics       Date:  2010-04       Impact factor: 3.940

6.  The expression of phospho-AKT, phospho-mTOR, and PTEN in extrahepatic cholangiocarcinoma.

Authors:  Joon-Yong Chung; Seung-Mo Hong; Byeong Yeob Choi; Hyungjun Cho; Eunsil Yu; Stephen M Hewitt
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

7.  Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis.

Authors:  Gerard J Oakley; Kim Fuhrer; Raja R Seethala
Journal:  Mod Pathol       Date:  2008-09-26       Impact factor: 7.842

Review 8.  Tissue microarrays as a tool in the discovery and validation of tumor markers.

Authors:  Stephen M Hewitt
Journal:  Methods Mol Biol       Date:  2009

9.  Use of human vascular tissue microarrays for measurement of advanced glycation endproducts.

Authors:  Marc K Halushka; Elizabeth Selvin; Jie Lu; Anne M Macgregor; Toby C Cornish
Journal:  J Histochem Cytochem       Date:  2009-02-16       Impact factor: 2.479

Review 10.  Targeted proteomics for validation of biomarkers in clinical samples.

Authors:  Xiaoying Ye; Josip Blonder; Timothy D Veenstra
Journal:  Brief Funct Genomic Proteomic       Date:  2008-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.